Why it was recalled
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
Product description
TRIPENICOL S Antifungal Solution (Undecylenic Acid 25%), 1.25 FL OZ (37.5 mL) bottle, Manufactured For: Trifluent Pharma, LLC, San Antonio, TX 78213, NDC 73352-550-01.
Lot numbers, UPCs & expiration codes
Lot #BL3411R, Exp 6/8/2027
Where it was sold
Nationwide in the USA
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0694-2026
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- Apr 8, 2026
- FDA report date
- Jul 8, 2026
- Quantity
- 144 bottles
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Blaine Labs Inc
Original FDA data
Every field from FDA enforcement report D-0694-2026, exactly as published.
Show all FDA fields
- City
- Santa Fe Springs
- State
- CA
- Status
- Ongoing
- Country
- United States
- Event ID
- 98731
- Address
- 11037 Lockport Pl
- Code information
- Lot #BL3411R, Exp 6/8/2027
- Postal code
- 90670-4634
- Report date
- Jul 8, 2026
- Product type
- Drugs
- Recall number
- D-0694-2026
- Classification
- Class II
- Recalling firm
- Blaine Labs Inc
- Product quantity
- 144 bottles
- Reason for recall
- CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- TRIPENICOL S Antifungal Solution (Undecylenic Acid 25%), 1.25 FL OZ (37.5 mL) bottle, Manufactured For: Trifluent Pharma, LLC, San Antonio, TX 78213, NDC 73352-550-01.
- Distribution pattern
- Nationwide in the USA
- Recall initiation date
- Apr 8, 2026
- Initial firm notification
- Press Release
- Center classification date
- Jul 16, 2026